A Single-Dose, Bioequivalence Study of FMXIN001 4 mg Microspheres Powder

Clinical trial NCT04713709 · COMPLETED

Trial details

NCT number: NCT04713709
Sponsor: Nasus Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Opioid Overdose

Start date: 2021-01-31
Primary completion: 2021-03-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.